Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: May 23, 2005
Last updated: February 19, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):